Orion Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-300
Closed -$4.53K 500
2024
Q1
$4.53K Hold
300
﹤0.01% 426
2023
Q4
$6.46K Hold
300
﹤0.01% 407
2023
Q3
$5.58K Buy
+300
New +$7K ﹤0.01% 412
2023
Q2
Sell
-300
Closed -$7.77K 394
2023
Q1
$7.77K Hold
300
0.01% 381
2022
Q4
$7.09K Hold
300
0.01% 327
2022
Q3
$8K Hold
300
0.01% 329
2022
Q2
$10K Sell
300
-200
-40% -$8.49K 0.01% 321
2022
Q1
$36K Sell
500
-7,550
-94% -$544K 0.02% 229
2021
Q4
$739K Hold
8,050
0.42% 54
2021
Q3
$1.02M Buy
8,050
+200
+3% +$29.1K 0.62% 44
2021
Q2
$1.3M Sell
7,850
-200
-2% -$32.4K 0.81% 29
2021
Q1
$1.46M Hold
8,050
1.02% 25
2020
Q4
$1.51M Buy
+8,050
New +$1.64M 1.12% 23

Other funds holding TDOC

Orion Capital Management's TDOC Position: Q2 2024 in Review

Orion Capital Management sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 300 shares — an estimated $4.53K sold.

Orion Capital Management first reported a position in TDOC in Q4 2020 and held it in 13 quarters. The position peaked at $1.51M in Q4 2020. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Orion Capital Management reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Orion Capital Management sold 300 Teladoc Health shares in Q2 2024, an estimated $4.53K.
  • Orion Capital Management first reported a position in Teladoc Health in Q4 2020 and held it in 13 quarters.
  • Orion Capital Management's Teladoc Health position peaked at $1.51M in Q4 2020.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Orion Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.